Feature

Patients with mental illness a priority for COVID vaccine, experts say


 

An argument for fairness

Paul S. Appelbaum, MD, professor of psychiatry, medicine, and law at Columbia University, New York, also believes those with severe mental illness should be a priority group for a COVID vaccine.

“When we’re prioritizing groups for a COVID-19 vaccine, let’s not forget that people with serious mental illness have much lower life expectancies, more obesity, and more undiagnosed chronic conditions. They should be a priority group,” Dr. Appelbaum said in an interview.

“The argument for including people with severe mental illnesses among the vulnerable populations who should be prioritized for receipt of a COVID-19 vaccine is an argument for fairness in constructing that group,” he added.

“Like people with other chronic conditions associated with poor outcomes after SARS-CoV-2 infection, people with severe mental illnesses are more likely to be hospitalized and more likely to die. Although they are often systematically ignored when decisions are made about allocation of resources, there is some hope that, with enough public attention to this issue, they can be included this time,” Dr. Appelbaum said.

Dr. De Hert and Dr. Applebaum disclosed no relevant financial relationships.

This article first appeared on Medscape.com.

Pages

Recommended Reading

Pfizer vaccine data show 90% efficacy in early results
MDedge Rheumatology
Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?
MDedge Rheumatology
Food insecurity called urgent issue you must address
MDedge Rheumatology
United States adds nearly 74,000 more children with COVID-19
MDedge Rheumatology
Hospitals poised to launch first COVID-19 vaccines in clinicians
MDedge Rheumatology
Great Barrington coauthor backs off strict reliance on herd immunity
MDedge Rheumatology
FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapy
MDedge Rheumatology
What happened to melanoma care during COVID-19 sequestration
MDedge Rheumatology
Moral distress: COVID-19 shortages prompt tough decisions at bedside
MDedge Rheumatology
Search for a snakebite drug might lead to a COVID treatment, too
MDedge Rheumatology